Nirmatrelvir-Ritonavir, Molnupiravir Cut Mortality Risk In Patients With COVID-19, Data Indicate

Healio (6/6, Bascom) reports, “As an outpatient treatment for COVID-19, the antivirals Paxlovid” (nirmatrelvir-ritonavir) “and Lagevrio” (molnupiravir) “were both associated with reduced mortality rates, but only Paxlovid was associated with a reduction i...